Mozambique: Over 3,000 Patients Under New TB Combined Therapy

Maputo — 3,413 patients across Mozambique are undertaking the new tuberculosis preventive therapy, coupling strong doses of isoniazid (H) and rifapentine (P), to prevent simple and non-contagious cases from worsening and increasing the number of infected people.

The new therapy, launched in March by the Mozambican government in partnership with the IMPAACT4TB consortium, is a four year project which introduces a new approach not only to deal with latent infection but also to fight abandonment of treatment and thus increase efficacy levels.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.